Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 314 (5799): 602-603

Copyright © 2006 by the American Association for the Advancement of Science

BIOMEDICINE:
Avoiding Collateral Damage in Alzheimer's Disease Treatment

Charles Glabe

Although beta-secretase has been considered a relatively harmless target for drugs against Alzheimer's disease, such drugs may damage nearby nerves.


The author is in the Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697, USA. E-mail: cglabe{at}uci.edu



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882